Advanced polymeric vectors for the treatment of site-specific rheumatic musculoskeletal diseases
Researchers from ÚMCH, together with colleagues from BFU and the Institute of Rheumatology, developed polymer vectors with optimized drug activation for the treatment of rheumatic diseases.